# Withdrawal, the return of an illness and new symptoms Someone may feel worse after a change in treatment. They might think, “I can no longer cope without the medicine” or “The illness has returned.” But feeling similar does not establish the cause. Assessment needs the prescribing history, what actually changed and what is happening now. Help can begin before there is a precise explanation. ## First consider how urgently help is needed An immediate threat to life or risk of self-harm calls for urgent local help. Do not wait until it becomes clear whether the condition relates to withdrawal, the previous illness or another cause. Discussing medication and preparing notes can wait. [NIMH, Depression](https://www.nimh.nih.gov/health/publications/depression). If suicidal thoughts appear, tell a professional immediately; danger or an inability to keep yourself safe requires a local emergency route. The NHS also warns that some serious adverse reactions require urgent medical help. This article does not list every such reaction or replace individual assessment. [NHS, antidepressants](https://www.nhs.uk/medicines/antidepressants/). When there is no immediate danger, you can contact the prescriber and say, “I have felt worse since the changes; I need to discuss possible causes and further help.” That contact does not first require proving withdrawal, accepting an addiction diagnosis or compiling a perfect diary. ## Similar feelings can have different explanations Withdrawal symptoms arise in connection with reducing or stopping a particular medicine, sometimes with missed doses. A returning illness means a recurrence of the condition being treated. A side effect or another factor is a further possibility that cannot be excluded simply because treatment recently changed. For example, the NHS describes sleep problems, anxiety, mood changes and physical sensations during antidepressant withdrawal. Some complaints may resemble the previous condition. Symptoms can be severe, begin later than expected and persist for a long time. This does not permit every deterioration to be labelled withdrawal from a distance, but the absence of an immediate reaction does not exclude it either. “This feeling is new to me” is important information, rather than ready-made proof of a new illness. “It happened before” does not establish recurrence either. A person's observations deserve attention even when there is no final label yet. Describing a concrete change to a professional is more useful than arguing about labels. ## How the history helps the conversation The Royal College of Psychiatrists' information on stopping antidepressants discusses when complaints begin and how sensations differ from those present before treatment. This information supports a conversation with the prescriber. It does not form an independent test: a single time interval or sensation cannot establish the cause. [RCPsych, stopping antidepressants](https://www.rcpsych.ac.uk/mental-health/treatments-and-wellbeing/stopping-antidepressants). You can recall why treatment was prescribed, which changes were agreed and what actually happened. If information is incomplete, say so. There is no need to create a new missed dose, stop or restart in order to produce a more convincing history. The body's response to a home experiment does not replace medical assessment. “Before” and “after” help reconstruct the sequence. Establishing cause takes more: a professional may need to assess other prescriptions and the current condition. Someone does not have to work out every interaction on their own before seeking help. It matters to preserve information about both helpful treatment effects and difficulties. ## Different medicines need different assessment A shared question about possible withdrawal does not mean that every medicine carries the same risk. The FDA's benzodiazepine warning states that physical dependence can occur even with prescribed use, and abrupt stopping or overly rapid reduction can cause dangerous reactions, including seizures. This is an example concerning a particular class, rather than a prediction for every psychiatric medicine. [FDA, benzodiazepine warning](https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class). Seizures or another life-threatening condition require immediate local emergency help. A scheduled routine appointment does not make waiting safe. Do not look for another substance at home to “compensate” for what is happening. This article provides no withdrawal regimen, list of substitutes or calendar for several medicines. Changes to a prescribed medicine should be discussed with the responsible professional. If an unplanned change has already occurred, report it; shame and fear of judgement should not become an additional barrier to help. ## Preserve treatment benefit and the opportunity for review Real relief, better sleep or the ability to work matter. They do not establish that a prescription is suitable forever, but difficulty stopping does not erase earlier benefits. RCPsych's information distinguishes physical adaptation from addiction; an individual discussion considers why treatment was prescribed, its benefits and emerging difficulties. There is no need to prove independence by giving up medication. Both wanting to continue useful treatment and wanting to discuss stopping deserve a conversation. Duration alone does not establish a substance use disorder, weakness or an intention by the system to retain a patient. Assessment needs specific circumstances. Do not stop, restart or change treatment independently to test the cause of symptoms. This does not mean enduring every reaction or automatically continuing a dangerous prescription: serious deterioration calls for timely medical assessment, with decisions about changes based on the person's condition. Love, meaning and a new environment may support them without replacing necessary help. ## Five optional fields for contacting help These are the author's preparation prompts for a conversation, rather than a diagnostic scale or treatment plan. Use only what is already known, without carrying out a new experiment. Any field can be left blank; notes are unnecessary during danger. 1. **Prescription and purpose.** What was prescribed, and for which complaint or condition, if known. 2. **Actual change.** What has already changed in treatment, what was agreed and where information is uncertain. Do not create a change to observe it. 3. **Previous and new feelings.** What resembles the condition before treatment, what differs and when it became noticeable, as far as you remember. 4. **Benefits, difficulties and other help.** What helped, how daily life is changing now and which other prescriptions or substances should be discussed. 5. **An accessible contact.** Whom you can contact, which access conditions need clarification and what voluntary help from a relative is possible. One sentence is acceptable in place of a detailed report: “Difficulties I do not understand appeared after the changes.” Seeking help does not depend on complete notes, perfect motivation or every relative agreeing. ## Agree on a clear next step For a routine contact, clarify who can assess the current condition and prescribing history. It is important to distinguish medical assessment from a supportive conversation: booking a counsellor alone does not resolve a dangerous reaction or withdrawal. SAMHSA suggests clarifying appointment arrangements and barriers beforehand. You can ask about language, cost, contact format and where to turn if that service is unsuitable. Confidentiality and the sharing of medical information should be clarified with the particular service; conditions differ between countries. [SAMHSA, setting up an appointment](https://www.samhsa.gov/find-support/health-care-or-support/how-to-set-up-an-appointment). At the appointment, it helps to ask what has been established, what remains unknown, who continues care and how to make contact if things worsen. An individual plan may need review. Asking for clarity does not mean that the patient should calculate the dose, pace or stopping point independently. ## Relatives help within agreed boundaries With an adult's consent, a relative can help recall information already known, arrange interpretation, transport or company. They are not obliged to identify the cause of symptoms, choose medication or become solely responsible for treatment. Manageable limits and their own support matter. [SAMHSA, caring for yourself while supporting someone](https://www.samhsa.gov/find-support/helping-someone/caring-for-yourself). Secret checks, withholding medication and demanding proof of “independence” do not replace an agreement about help. A child must not be tasked with monitoring an adult's medicine use, mood or safety. Where there are threats or violence, protecting the person harmed and children matters in its own right; involvement does not require enduring harm. After making contact, you can discuss whether an actual assessment was received and the next route is clear. A new booking or a new label for the condition does not yet establish that help was provided. Someone is entitled to ask for explanations, report benefits and difficulties together, and keep seeking suitable support. ## Sources and limits Selected sources were checked on 14 October 2026. This article examines changes in psychiatric treatment using antidepressants and benzodiazepines as examples; it does not transfer every feature of one class to another. It does not determine the cause of a reader's symptoms, propose independent changes to treatment or establish access rules for every country. - [NHS, Antidepressants](https://www.nhs.uk/medicines/antidepressants/) — page reviewed 12 June 2025; the main extracted text was personally read, including stopping, possible symptoms and urgent help. Linked prescribing documents and studies were not verified. - [Royal College of Psychiatrists, Stopping antidepressants](https://www.rcpsych.ac.uk/mental-health/treatments-and-wellbeing/stopping-antidepressants) — March 2024; selected sections on speaking with the prescriber, distinguishing complaints and physical adaptation were read, with publication metadata checked separately. A full-page reading and technical regimens are not claimed; regimens were not transferred to this article. - [FDA, benzodiazepine warning](https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class) — 23 September 2020; specific statements on physical dependence and dangerous withdrawal were read. This is a US regulator's communication, rather than instructions for every medicine or country. - [NIMH, Depression](https://www.nimh.nih.gov/health/publications/depression) — revised 2024; the author's own verified reading on urgent help during immediate danger was used, rather than a diagnosis of the reader. - [SAMHSA, How to Set Up an Appointment](https://www.samhsa.gov/find-support/health-care-or-support/how-to-set-up-an-appointment) — 24 April 2023; the author's own reading of substantive first-contact and access content, reused within this series. - [SAMHSA, Caring for Yourself](https://www.samhsa.gov/find-support/helping-someone/caring-for-yourself) — 24 April 2023; the author's own reading of substantive content on manageable boundaries and personal support, reused within this series. ## Tags medicines; withdrawal; antidepressants; benzodiazepines; physical dependence; recurrence of illness; side effects; treatment history; shared decisions; access to help; relatives' boundaries; patient autonomy ## About the authors Andrey Zarinsh is the author and founder of United Wisdom. He explores inner transformation, the unity of traditions, intercultural dialogue and contemporary spiritual discipline. Instagram: @andrey.zarinsh. Maria Evilkut is a co-author of United Wisdom. Alongside her research, she seeks to test these ideas in practice and observe how principles of unity and mutual understanding work in real life between people and cultures. Instagram: @ilkutki.